AORT files Form 144 to sell 17,887 shares

AORT filed a Form 144 notifying the proposed sale of 17,887 shares of common stock dated 02/27/2026 associated with restricted stock vesting.

Rhea-AI Filing Summary

AORT filed a Form 144 notifying the proposed sale of 17,887 shares of common stock dated 02/27/2026 associated with restricted stock vesting.

The filing also reports prior sales by James Mackin: 30,921 shares on 12/03/2025, 20,962 shares on 02/23/2026, 13,936 shares on 02/24/2026, and 14,911 shares on 03/02/2026, with each sale accompanied by the reported sale proceeds in the excerpt.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the AORT Form 144 disclose?

The filing discloses a proposed sale of 17,887 common shares dated 02/27/2026. It links those shares to restricted stock vesting and lists multiple past sales by James Mackin with dates and share counts as shown in the excerpt.

Who reported transactions in the AORT Form 144?

James Mackin is the reporting party shown. The excerpt lists his name and address and four executed sales on 12/03/2025, 02/23/2026, 02/24/2026, and 03/02/2026 with corresponding share amounts and proceeds.

How many shares did James Mackin sell recently according to the filing?

The excerpt shows sales of 30,921; 20,962; 13,936; and 14,911 shares on listed dates. Each sale line in the excerpt includes the sale date and the dollar proceeds reported alongside the share counts.

What is the reason given for the 17,887 shares to be sold?

The excerpt ties the 17,887 shares to restricted stock vesting dated 02/27/2026. The Securities To Be Sold row explicitly lists Restricted Stock Vesting and classifies the source as Issuer with a compensation purpose.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/03/2026 - 04:19 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001408470
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ARTIVION, INC.
SEC File Number	001-13165
Address of Issuer	1655 ROBERTS BOULEVARD N W KENNESAW GEORGIA 30144
Phone	7704193355
Name of Person for Whose Account the Securities are To Be Sold	Mackin James P
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	17887	675692.16	47883897	03/03/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/27/2026	Restricted Stock Vesting	Issuer			17887	02/27/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
James Mackin 1655 Roberts Boulevard N.W. Kennesaw GA 30144	Common	12/03/2025	30921	1405693.40
James Mackin 1655 Roberts Boulevard N.W. Kennesaw GA 30144	Common	02/23/2026	20962	787909.17
James Mackin 1655 Roberts Boulevard N.W. Kennesaw GA 30144	Common	02/24/2026	13936	497416.25
James Mackin 1655 Roberts Boulevard N.W. Kennesaw GA 30144	Common	03/02/2026	14911	566989.28

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	03/03/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Louis Kurnick, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for James Mackin
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)